Cardiovascular disease emerges from interactions between inherited risk, molecular programmes, and tissue-scale remodelling that clinicians observe through imaging. A new preprint on arXiv outlines a framework for combining these perspectives, proposing that cardiac imaging can serve as an anchor for multiomics studies. The authors argue that integrating imaging with bulk, single-cell, and spatial transcriptomics could help connect molecular changes to the structural and functional alterations seen in patients.
The paper is a perspective or review rather than a new experimental study, and it does not present original data. It emphasises that health systems already routinely generate large volumes of imaging, which could be leveraged to contextualise molecular measurements. The authors suggest that spatial transcriptomics in particular offers a way to map gene expression directly onto tissue architecture, potentially bridging the gap between biopsy-level molecular data and whole-organ imaging.
Because this is a single preprint, its proposals have not yet been independently validated or widely discussed. The claims are internally consistent, but there are no contrasting sources to compare against. Still, the framework highlights a growing ambition in cardiovascular research: to integrate clinical imaging with high-resolution molecular profiling in order to better understand disease mechanisms and, eventually, improve diagnosis and treatment.